Prostatic Neoplasms, Castration-Resistant Completed Phase Trials for Radium Ra 223 dichloride (DB08913)

IndicationStatusPhase
DBCOND0001230 (Prostatic Neoplasms, Castration-Resistant)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02450812Non-interventional Study With Ra-223 Dichloride Assessing Overall Survival and Effectiveness Predictors for mCRPC Patients in a Real Life Setting in Germany
NCT03563014A Local Retrospective Observational Study to Evaluate the Treatment Patterns of mCRPC Patients in Belgium Treated With Radium-223
NCT02899104Navigant Study- Treatment Patterns in mCRPC (Metastatic Castrate Resistant Prostate Cancer )